An O Antigen Capsule Modulates Bacterial Pathogenesis in Shigella sonnei

PLoS Pathogens

Volumn 11, Issue 3, 2015, Pages 1-26

  Caboni, Mariaelena ^a   Pédron, Thierry ^b   Rossi, Omar ^a   Goulding, David ^c   Pickard, Derek ^c   Citiulo, Francesco ^a   MacLennan, Calman A ^a   Dougan, Gordon ^c   Thomson, Nicholas R ^c   Saul, Allan ^a   Sansonetti, Philippe J ^b,d   Gerke, Christiane ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b INSTITUT PASTEUR   (France)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d Centre de Recherche Interdisciplinaire en Biologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; O ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENIC MODULATION; ARTICLE; BACTERIAL CAPSULE; CELL INVASION ASSAY; COLONY FORMING UNIT; CONTROLLED STUDY; DNA SEQUENCE; EPITHELIUM CELL; FLOW CYTOMETRY; GEL PERMEATION CHROMATOGRAPHY; GENE DELETION; HELA CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; INFLAMMATION; MOLECULAR WEIGHT; MOUSE; MUTANT MOUSE STRAIN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OPERON; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTON NUCLEAR MAGNETIC RESONANCE; RABBIT; SENSITIVITY ANALYSIS; SHIGELLA SONNEI; SILVER STAINING; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; GENE SILENCING; GENETICS; METABOLISM; PATHOGENICITY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS; SHIGELLA; SHIGELLA FLEXNERI 2A; SHIGELLA SONNEI;

ANIMALS; BACTERIAL CAPSULES; GENE KNOCKDOWN TECHNIQUES; O ANTIGENS; RABBITS; SHIGELLA SONNEI;

EID: 84926464634     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004749     Document Type: Article

References (62)

1. Schroeder GN, Hilbi H, Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev. 2008;21: 134–156. doi: 10.1128/CMR.00032-07 18202440
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380: 2095–2128. doi: 10.1016/S0140-6736(12)61728-0 23245604
3. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382: 209–222. doi: 10.1016/S0140-6736(13)60844-2 23680352
4. Bennish ML, Potentially lethal complications of shigellosis. Rev Infect Dis. 1991;13 Suppl 4: S319–S324. 2047657
5. Struelens MJ, Patte D, Kabir I, Salam A, Nath SK, Butler T, Shigella septicemia: prevalence, presentation, risk factors, and outcome. J Infect Dis. 1985;152: 784–790. 4045231
6. Duncan B, Fulginiti VA, Sieber OF, JrRyan KJ, Shigella sepsis. Am J Dis Child. 1981;135: 151–154. 7468548
7. Keddy KH, Sooka A, Crowther-Gibson P, Quan V, Meiring S, Cohen C, et al. Systemic shigellosis in South Africa. Clin Infect Dis. 2012;54: 1448–1454. doi: 10.1093/cid/cis224 22474223
8. Kligler RM, Hoeprich PD, Shigellemia. West J Med. 1984;141: 375–378. 6506675
9. Liu B, Knirel YA, Feng L, Perepelov AV, Senchenkova SN, Wang Q, et al. Structure and genetics of Shigella O antigens. FEMS Microbiol Rev. 2008;32: 627–653. doi: 10.1111/j.1574-6976.2008.00114.x 18422615
10. Levine MM, Kotloff KL, Barry EM, Pasetti MF, Sztein MB, Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol. 2007;5: 540–553. 17558427
11. Bennish ML, Harris JR, Wojtyniak BJ, Struelens M, Death in shigellosis: incidence and risk factors in hospitalized patients. J Infect Dis. 1990;161: 500–506. 2313128
12. Vinh H, Nhu NT, Nga TV, Duy PT, Campbell JI, Hoang NV, et al. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis. 2009;9: 204. doi: 10.1186/1471-2334-9-204 20003464
13. Ud-Din AI, Wahid SU, Latif HA, Shahnaij M, Akter M, Azmi IJ, et al. Changing trends in the prevalence of Shigella species: emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh. PLoS One. 2013;8: e82601. doi: 10.1371/journal.pone.0082601 24367527
14. Karaolis DK, Lan R, Reeves PR, Sequence variation in Shigella sonnei (Sonnei), a pathogenic clone of Escherichia coli, over four continents and 41 years. J Clin Microbiol. 1994;32: 796–802. 7910830
15. Holt KE, Baker S, Weill FX, Holmes EC, Kitchen A, Yu J, et al. Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe. Nat Genet. 2012;44: 1056–1059. doi: 10.1038/ng.2369 22863732
16. Robin G, Cohen D, Orr N, Markus I, Slepon R, Ashkenazi S, et al. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection. J Infect Dis. 1997;175: 1128–1133. 9129076
17. Kenne L, Lindberg B, Petersson K, Katzenellenbogen E, Romanowska E, Structural studies of the O-specific side-chains of the Shigella sonnei Phase I lipopolysaccharide. Carbohydr Res. 1980;78: 119–126.
18. Xu DQ, Cisar JO, Ambulos JN, Jr.Burr DH, Kopecko DJ, Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live Salmonella vaccine vector. Infect Immun. 2002;70: 4414–4423. 12117952
19. Morona R, van den Bosch L, Manning PA, Molecular, genetic, and topological characterization of O-antigen chain length regulation in Shigella flexneri. J Bacteriol. 1995;177: 1059–1068. 7532168
20. Jiang Y, Yang F, Zhang X, Yang J, Chen L, Yan Y, et al. The complete sequence and analysis of the large virulence plasmid pSS of Shigella sonnei. Plasmid. 2005;54: 149–159. 16122562
21. Sandlin RC, Lampel KA, Keasler SP, Goldberg MB, Stolzer AL, Maurelli AT, Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane. Infect Immun. 1995;63: 229–237. 7528731
22. Carter JA, Blondel CJ, Zaldívar M, Álvarez SA, Marolda CL, Valvano MA, et al. O-antigen modal chain length in Shigella flexneri 2a is growth-regulated through RfaH-mediated transcriptional control of the wzy gene. Microbiology. 2007;153: 3499–3507. 17906147
23. Morona R, Daniels C, van den Bosch L, Genetic modulation of Shigella flexneri 2a lipopolysaccharide O antigen modal chain length reveals that it has been optimized for virulence. Microbiology. 2003;149: 925–939. 12686635
24. West NP, Sansonetti P, Mounier J, Exley RM, Parsot C, Guadagnini S, et al. Optimization of virulence functions through glucosylation of Shigella LPS. Science. 2005;307: 1313–1317. 15731456
25. Kopecko DJ, Washington O, Formal SB, Genetic and physical evidence for plasmid control of Shigella sonnei form I cell surface antigen. Infect Immun. 1980;29: 207–214. 6249756
26. Sansonetti PJ, Kopecko DJ, Formal SB, Shigella sonnei plasmids: evidence that a large plasmid is necessary for virulence. Infect Immun. 1981;34: 75–83. 6271687
27. Roberts IS, The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol. 1996;50: 285–315. 8905082
28. Whitfield C, Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem. 2006;75: 39–68. 16756484
29. Cuthbertson L, Mainprize IL, Naismith JH, Whitfield C, Pivotal roles of the outer membrane polysaccharide export and polysaccharide copolymerase protein families in export of extracellular polysaccharides in gram-negative bacteria. Microbiol Mol Biol Rev. 2009;73: 155–177. doi: 10.1128/MMBR.00024-08 19258536
30. Peleg A, Shifrin Y, Ilan O, Nadler-Yona C, Nov S, Koby S, et al. Identification of an Escherichia coli operon required for formation of the O-antigen capsule. J Bacteriol. 2005;187: 5259–5266. 16030220
31. Shifrin Y, Peleg A, Ilan O, Nadler C, Kobi S, Baruch K, et al. Transient shielding of intimin and the type III secretion system of enterohemorrhagic and enteropathogenic Escherichia coli by a group 4 capsule. J Bacteriol. 2008;190: 5063–5074. doi: 10.1128/JB.00440-08 18502854
32. Gibson DL, White AP, Snyder SD, Martin S, Heiss C, Azadi P, et al. Salmonella produces an O-antigen capsule regulated by AgfD and important for environmental persistence. J Bacteriol. 2006;188: 7722–7730. 17079680
33. Berlanda Scorza F, Colucci AM, Maggiore L, Sanzone S, Rossi O, Ferlenghi I, et al. High yield production process for Shigella outer membrane particles. PLoS One. 2012;7: e35616. doi: 10.1371/journal.pone.0035616 22701551
34. Robbins JB, Kubler-Kielb J, Vinogradov E, Mocca C, Pozsgay V, Shiloach J, et al. Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates. Proc Natl Acad Sci U S A. 2009;106: 7974–7978. doi: 10.1073/pnas.0900891106 19346477
35. Droge W, Lehmann V, Luderitz O, Westphal O, Structural investigations on the 2-keto-3-deoxyoctonate region of lipopolysaccharides. Eur J Biochem. 1970;14: 175–184. 4315842
36. Marteyn B, Gazi A, Sansonetti P, Shigella: a model of virulence regulation in vivo. Gut Microbes. 2012;3: 104–120. doi: 10.4161/gmic.19325 22356862
37. Ameho CK, Adjei AA, Harrison EK, Takeshita K, Morioka T, Arakaki Y, et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut. 1997;41: 487–493. 9391247
38. Madonna GS, Allen RC, Shigella sonnei phase I and phase II: susceptibility to direct serum lysis and opsonic requirements necessary for stimulation of leukocyte redox metabolism and killing. Infect Immun. 1981;32: 153–159. 7012027
39. Okamura N, Nakaya R, Suzuki K, Kondo S, Hisatsune K, Imagawa Y, et al. Differences among Shigella spp. in susceptibility to the bactericidal activity of human serum. J Gen Microbiol. 1988;134: 2057–2065. 3246597
40. Dharmasena MN, Hanisch BW, Wai TT, Kopecko DJ, Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a. Int J Med Microbiol. 2013;303: 105–113. doi: 10.1016/j.ijmm.2013.01.001 23474241
41. Batta G, Liptak A, Schneerson R, Pozsgay V, Conformational stabilization of the altruronic acid residue in the O-specific polysaccharide of Shigella sonnei/Plesiomonas shigelloides. Carbohydr Res. 1997;305: 93–99. 9534229
42. Snyder DS, Gibson D, Heiss C, Kay W, Azadi P, Structure of a capsular polysaccharide isolated from Salmonella Enteritidis. Carbohydr Res. 2006;341: 2388–2397. 16857179
43. Schembri MA, Dalsgaard D, Klemm P, Capsule shields the function of short bacterial adhesins. J Bacteriol. 2004;186: 1249–1257. 14973035
44. Schembri MA, Blom J, Krogfelt KA, Klemm P, Capsule and fimbria interaction in Klebsiella pneumoniae. Infect Immun. 2005;73: 4626–4633. 16040975
45. Virji M, Makepeace K, Peak IR, Ferguson DJ, Jennings MP, Moxon ER, Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. Mol Microbiol. 1995;18: 741–754. 8817495
46. Lo H, Tang CM, Exley RM, Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development. Lancet Infect Dis. 2009;9: 418–427. doi: 10.1016/S1473-3099(09)70132-X 19555901
47. Raffatellu M, Santos RL, Chessa D, Wilson RP, Winter SE, Rossetti CA, et al. The capsule encoding the viaB locus reduces interleukin-17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi. Infect Immun. 2007;75: 4342–4350. 17591794
48. Hong M, Payne SM, Effect of mutations in Shigella flexneri chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance. Mol Microbiol. 1997;24: 779–791. 9194705
49. Formal SB, Kent TH, May HC, Palmer A, Falkow S, LaBrec EH, Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine. J Bacteriol. 1966;92: 17–22. 4957431
50. Formal SB, Dammin GJ, LaBrec EH, Schneider H, Experimental Shigella infections: characteristics of a fatal infection produced in guinea pigs. J Bacteriol. 1958;75: 604–610. 13538931
51. Rossi O, Pesce I, Giannelli C, Aprea S, Caboni M, Citiulo F, et al. Modulation of Endotoxicity of Shigella Generalized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications: Relative Activation of TLR4 and TLR2 Pathways in Different Mutants. J Biol Chem. 2014;289: 24922–24935. doi: 10.1074/jbc.M114.566570 25023285
52. Chaveroche MK, Ghigo JM, d'Enfert C, A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans. Nucleic Acids Res. 2000;28: E97. 11071951
53. Makino S, Sasakawa C, Yoshikawa M, Genetic relatedness of the basic replicon of the virulence plasmid in shigellae and enteroinvasive Escherichia coli. Microb Pathog. 1988;5: 267–274. 3070262
54. Trieu-Cuot P, Poyart-Salmeron C, Carlier C, Courvalin P, Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Res. 1990;18: 3660. 2163525
55. Datsenko KA, Wanner BL, One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 2000;97: 6640–6645. 10829079
56. Maxson ME, Darwin AJ, Identification of inducers of the Yersinia enterocolitica phage shock protein system and comparison to the regulation of the RpoE and Cpx extracytoplasmic stress responses. J Bacteriol. 2004;186: 4199–4208. 15205422
57. Barzu S, Nato F, Rouyre S, Mazie JC, Sansonetti P, Phalipon A, Characterization of B-cell epitopes on IpaB, an invasion-associated antigen of Shigella flexneri: identification of an immunodominant domain recognized during natural infection. Infect Immun. 1993;61: 3825–3831. 7689541
58. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F, Colorimetric Method for Determination of Sugars and Related Substances. 1956;28: 350–356.
59. Westphal O, Jann K, Bacterial lipopolysaccharides: extraction with phenol-water and further application of the procedure. 1965;5: 83–91.
60. Tokuyasu KT, Specer DL, Goodman RD, Leinwand Immunocytochemistry on ultrathin cryosections. In: Cells, a laboratory manual. Subcellular localization of genes and their products. Cold Spring Harbour: Laboratory Press; 1997. pp. 131.1–131.27.
61. Schnupf P, Sansonetti PJ, Quantitative RT-PCR profiling of the rabbit immune response: assessment of acute Shigella flexneri infection. PLoS One. 2012;7: e36446. doi: 10.1371/journal.pone.0036446 22675469
62. Micoli F, Rondini S, Gavini M, Pisoni I, Lanzilao L, Colucci AM, et al. A scalable method for O-antigen purification applied to various Salmonella serovars. Anal Biochem. 2013;434: 136–145. doi: 10.1016/j.ab.2012.10.038 23142430